MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Avinger DPO Ratio 2011-2026 | AVGR
Annual DPO Ratio Avinger
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.5 | 65.8 | 56.8 | 41.2 | 38.6 | 64.2 | 35.7 | 40.6 | 62.7 | 56.8 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 65.8 | 35.7 | 50.8 |
Quarterly DPO Ratio Avinger
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.4 | 45.7 | 45.9 | - | 31 | 29.9 | 41.8 | - | 41.8 | 58.7 | 85.8 | - | 64.5 | 46.6 | 40.6 | - | 41.5 | 57.2 | 35.2 | - | 38.7 | 37.8 | 56.3 | - | 70.9 | 48.3 | 78.1 | - | 35.5 | 29.6 | 32.2 | - | 39.2 | 40.2 | 36.9 | - | 58 | 62.1 | 75.3 | - | 62.8 | 47 | 30.8 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 85.8 | 29.6 | 48.7 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 11.94 | -1.08 % | $ 1.61 B | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 9.07 | -3.3 % | $ 257 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 23.78 | 0.72 % | $ 201 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 36.67 | -0.19 % | $ 5.46 K | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Globus Medical
GMED
|
33.1 | $ 90.0 | 1.58 % | $ 12.2 B | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.58 | -0.11 % | $ 122 M | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 1.83 | -3.68 % | $ 1.11 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.33 | 0.21 % | $ 719 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.4 | -1.73 % | $ 127 M |  France |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.03 | 3.35 % | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 85.11 | -0.61 % | $ 2.96 B | USA |
 |
Align Technology
ALGN
|
33.7 | $ 166.87 | -2.91 % | $ 12.5 B | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
34.4 | $ 30.99 | -5.06 % | $ 1.43 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.76 | -1.13 % | $ 370 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
LENSAR
LNSR
|
146 | $ 5.63 | -4.41 % | $ 67.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Medtronic PLC
MDT
|
76.2 | $ 86.42 | 0.15 % | $ 111 B | USA |
 |
Myomo
MYO
|
34.8 | $ 0.68 | -2.9 % | $ 28.5 M | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.05 | -1.94 % | $ 857 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Nevro Corp.
NVRO
|
61.7 | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.61 | 3.37 % | $ 38 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
56 | $ 9.67 | -0.31 % | $ 346 M | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 61.86 | -1.12 % | $ 91.6 B | USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 11.03 | 0.55 % | $ 1.66 B | USA |
 |
Insulet Corporation
PODD
|
22.5 | $ 202.46 | -0.51 % | $ 14.2 B | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 34.54 | 1.35 % | $ 1.07 B | USA |